CVS, Upbeat Q4

Top Analysts Upgrade CVS Health Stock (CVS) after Upbeat Q4 Results
CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’
CVS Health Jumps On Q4 Earnings Beat, But Downgrading To Hold
CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a recent >10% stock rally. See more.
CVS Health (NYSE:CVS) Upgraded at Leerink Partnrs
Leerink Partnrs upgraded shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a strong-buy rating in a research note published on Wednesday,Zacks.com reports. Leerink Partnrs also issued estimates for CVS Health’s FY2027 earnings at $8.
CVS Health Is About to Report Q4 Earnings Tomorrow. Here’s What to Expect
Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market opens on
CVS wins upgrade to buy as analyst sees more upside potential than its peers
A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits businesses.
CVS Health (CVS) Q4 2024 Earnings Call Transcript
Good morning, and thank you all for attending the CVS Health Q4 2024 earnings conference call. My name is Brika, and I will be your moderator for today's call. [Operator instructions] I would now like to pass the conference over to your host,
CVS Health: Earnings Beat Ignites Stock Rally
Shares of CVS Health Corporation (NYSE: CVS) experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's stock price increase comes after a period of decline,
Leerink Partners Upgrades CVS Health (CVS)
Fintel reports that on February 13, 2025, Leerink Partners upgraded their outlook for CVS Health (NYSE:CVS) from Market Perform to Outperform. Analyst Price Forecast Suggests 3.67% Upside As of January 28,
CVS Health 2024 Profits Eclipse $4.6 Billion Despite Rising Costs
CVS Health reported $4.6 billion in 2024 profit including $1.6 billion in the fourth quarter as its health insurance business ...
CVS Health steers through rising insurance costs in a strong fourth quarter
CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...
CVS Health beats quarterly profit estimates on lower medical costs
CVS Health reported a smaller-than-expected drop in fourth-quarter profit on Wednesday as the pace of medical cost increases ...
CVS Health stock soars on surprise boost from health insurance unit
CVS Health posted stronger-than-expected fourth quarter earnings Wednesday, including a narrowing of its key benefit-expense ...
CVS soars after fourth-quarter profit signals improvement
CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium ...
CVS Health Clears Low Earnings Bar, Leads S&P 500 On Return To Growth In '25
CVS Health topped fourth-quarter earnings estimates, but still saw profit slide 38% from a year ago. "We have continued to ...
Notable healthcare headlines for the week: J&J, CVS, Moderna, Biogen in focus
Wall Street snapped a two-week losing streak as headlines about President Donald Trump's remarks on tariff policy, economic data on inflation and corporate earnings took center stage. The S&P ...
Insurancenewsnet.com1d
After more than 1,000 layoffs, worries persist about CVS Health's future in Connecticut
HARTFORD— This week, the CEO of CVS Health expressed confidence that the company would turn around its embattled health-insurance business, the Hartford- based Aetna. CVS' reputation in Connecticut ...